Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients.

Grzegorzewska AE, Wobszal PM, Mostowska A, Jagodziński PP.

BMC Nephrol. 2012 Aug 3;13:75. doi: 10.1186/1471-2369-13-75.

2.

A randomized controlled trial of two schedules of hepatitis B vaccination in predialysed chronic renal failure patients.

Ahmadi F, Ramezani M, Razeghi E, Ranjbarnovin N, Khazaeipour Z.

Hepat Mon. 2012 May;12(5):344-8. doi: 10.5812/hepatmon.6438. Epub 2012 May 30.

3.

Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.

Fabrizi F, Dixit V, Messa P, Martin P.

Vaccine. 2012 Mar 16;30(13):2295-300. doi: 10.1016/j.vaccine.2012.01.064. Epub 2012 Jan 26.

PMID:
22285268
4.

Efficacy of HBV vaccination in various stages of chronic kidney disease: is earlier better?

Hashemi B, Mahdavi-Mazdeh M, Abbasi M, Hosseini-Moghaddam SM, Zinat NH, Ahmadi F.

Hepat Mon. 2011 Oct;11(10):816-20. doi: 10.5812/kowsar.1735143X.751.

6.

Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease.

Zitt E, Sprenger-Mähr H, Knoll F, Neyer U, Lhotta K.

Vaccine. 2012 Jan 20;30(5):931-5. doi: 10.1016/j.vaccine.2011.11.086. Epub 2011 Dec 4.

PMID:
22142584
7.

[Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].

Roznovský L, Tvrdík J, Kabieszová L, Petrousová L, Orságová I, Hozáková L, Lochman I, Kloudová A, Valkovský I, Letocha P, Schwarzová S, Hladík M, Zjevíková A.

Vnitr Lek. 2011 Oct;57(10):808-14. Czech.

PMID:
22097688
8.

[Seroconversion and immune response after anti-HBV vaccination in patients on chronic hemodialysis: comparison of two vaccines].

Polito P, Di Lullo L, Iannacci GR, Cecilia A, Galderisi C, Gorini A.

G Ital Nefrol. 2011 Sep-Oct;28(5):525-30. Italian.

PMID:
22028266
9.

Anti-HBs antibody persistence following primary vaccination with an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency.

Surquin M, Tielemans C, Nortier J, Jadoul M, Peeters P, Ryba M, Roznovsky L, Domán J, Barthelemy X, Crasta PD, Messier M, Houard S.

Hum Vaccin. 2011 Sep;7(9):913-8. doi: 10.4161/hv.7.9.16225. Epub 2011 Sep 1.

PMID:
21892006
10.

Interleukin-18 promoter polymorphism and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients.

Grzegorzewska AE, Wobszal P, Jagodziński PP.

Kidney Blood Press Res. 2012;35(1):1-8. doi: 10.1159/000329932. Epub 2011 Aug 10.

11.

A prospective study of hepatitis B vaccination - a comparison of responders versus nonresponders.

Brown CM, Donlon S, O'Kelly P, Casey AM, Collier C, Conlon PJ, Walshe JJ.

Ren Fail. 2011;33(3):276-9. doi: 10.3109/0886022X.2011.559300.

PMID:
21401350
12.

Immunogenicity and safety of an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials.

Tielemans CL, Vlasak J, Kosa D, Billiouw JM, Verpooten GA, Mezei I, Ryba M, Peeters PC, Mat O, Jadoul MY, Polakovic V, Dhaene M, Treille S, Kuriyakose SO, Leyssen M, Houard SA, Surquin M.

Vaccine. 2011 Feb 1;29(6):1159-66. doi: 10.1016/j.vaccine.2010.12.009. Epub 2010 Dec 16.

PMID:
21167859
13.

Tuberculin skin test, interferon-gamma assay, and T cells subpopulations in hemodialysis patients.

Petrescu L, Stancu S, Tardei G, Santimbrean C, Penescu M, Mircescu G.

J Ren Nutr. 2010 Sep;20(5 Suppl):S109-17. doi: 10.1053/j.jrn.2010.06.011.

PMID:
20797557
14.

Seroconversion rate to positivity for antibodies against core antigen of hepatitis B virus and duration of renal replacement therapy.

Grzegorzewska AE, Kaczmarek-Leki V, Młot-Michalska M, Niepolski L.

Nephrol Dial Transplant. 2011 Mar;26(3):970-6. doi: 10.1093/ndt/gfq499. Epub 2010 Aug 23.

PMID:
20732926
15.

The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature.

Alavian SM, Tabatabaei SV.

Vaccine. 2010 May 14;28(22):3773-7. doi: 10.1016/j.vaccine.2010.03.038. Epub 2010 Apr 4. Review.

PMID:
20371390
16.

Antibodies to core antigen of hepatitis B virus in patients on renal replacement therapy: association with demographic, clinical and laboratory data.

Grzegorzewska AE, Kurzawska-Firlej D, Ratajewski W, Frankiewicz D, Niepolski L, Kaczmarek A.

Nephron Clin Pract. 2010;114(3):c194-203. doi: 10.1159/000262302. Epub 2009 Nov 28.

PMID:
19955825
17.

Chronic hepatitis B: update 2009.

Lok AS, McMahon BJ.

Hepatology. 2009 Sep;50(3):661-2. doi: 10.1002/hep.23190. No abstract available.

18.

High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.

Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):203-8. doi: 10.1097/MPG.0b013e3181819ad4.

PMID:
19179883
19.

Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.

Johnson DW, Dent H, Yao Q, Tranaeus A, Huang CC, Han DS, Jha V, Wang T, Kawaguchi Y, Qian J.

Nephrol Dial Transplant. 2009 May;24(5):1598-603. doi: 10.1093/ndt/gfn684. Epub 2008 Dec 18.

PMID:
19096083
20.

Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.

Pippi F, Bracciale L, Stolzuoli L, Giaccherini R, Montomoli E, Gentile C, Filetti S, De Luca A, Cellesi C.

HIV Med. 2008 Aug;9(7):519-25. doi: 10.1111/j.1468-1293.2008.00598.x. Epub 2008 Jun 28.

Supplemental Content

Support Center